ข้ามไปยังเนื้อหา

Cardiothoracic and Vascular Surgery (Pediatrics)

การจัดการและการทำให้ขบวนการห้ามเลือดอยู่ในสภาวะที่เหมาะสม

Antifibrinolytic Agents

Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (เปิดหน้าต่างใหม่)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Source‎: Anesth Analg 2006;102(3):731-7.

Indexed‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (เปิดหน้าต่างใหม่)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (เปิดหน้าต่างใหม่)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Source‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

Indexed‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (เปิดหน้าต่างใหม่)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (เปิดหน้าต่างใหม่)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Source‎: PLoS One 2015;10(5):e0126514.

Indexed‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (เปิดหน้าต่างใหม่)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (เปิดหน้าต่างใหม่)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Source‎: Br J Anaesth 2013;110(4):615-21.

Indexed‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (เปิดหน้าต่างใหม่)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (เปิดหน้าต่างใหม่)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Source‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indexed‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (เปิดหน้าต่างใหม่)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (เปิดหน้าต่างใหม่)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Source‎: Ann Card Anaesth 2015;18(1):23-6.

Indexed‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (เปิดหน้าต่างใหม่)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (เปิดหน้าต่างใหม่)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Source‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indexed‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (เปิดหน้าต่างใหม่)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (เปิดหน้าต่างใหม่)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Source‎: Ann Thorac Surg 2011;92(3):958-63.

Indexed‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (เปิดหน้าต่างใหม่)

Recombinant Activated Factor VII (rFVIIa)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (เปิดหน้าต่างใหม่)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Source‎: Ann Thorac Surg 2007;84(1):161-8.

Indexed‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (เปิดหน้าต่างใหม่)

Pediatric off-label use of recombinant factor VIIa. (เปิดหน้าต่างใหม่)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Source‎: Pediatrics 2009;123(3):1066-72.

Indexed‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (เปิดหน้าต่างใหม่)

Factor VII for excessive bleeding following congenital heart disease surgery. (เปิดหน้าต่างใหม่)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Source‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

Indexed‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (เปิดหน้าต่างใหม่)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (เปิดหน้าต่างใหม่)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Source‎: Paediatr Anaesth 2009;19(4):364-70.

Indexed‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (เปิดหน้าต่างใหม่)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (เปิดหน้าต่างใหม่)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Source‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indexed‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (เปิดหน้าต่างใหม่)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (เปิดหน้าต่างใหม่)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Source‎: J Clin Anesth 2014;26(3):204-11.

Indexed‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (เปิดหน้าต่างใหม่)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (เปิดหน้าต่างใหม่)

Tobias JD, Berkenbosch JW, Russo P.

Source‎: Pediatr Crit Care Med 2003;4(1):49-51.

Indexed‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (เปิดหน้าต่างใหม่)

Recombinant activated factor VII in cardiac surgery: a systematic review. (เปิดหน้าต่างใหม่)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Source‎: Ann Thorac Surg 2007;83(2):707-14.

Indexed‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (เปิดหน้าต่างใหม่)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (เปิดหน้าต่างใหม่)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Source‎: Pediatr Crit Care Med 2009;10(5):572-82.

Indexed‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (เปิดหน้าต่างใหม่)

Coagulation Factor Concentrates

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (เปิดหน้าต่างใหม่)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Source‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

Indexed‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (เปิดหน้าต่างใหม่)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (เปิดหน้าต่างใหม่)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Source‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Indexed‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (เปิดหน้าต่างใหม่)

Topical Hemostatic Agents

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (เปิดหน้าต่างใหม่)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Source‎: Ann Surg 2010;251(2):217-28.

Indexed‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (เปิดหน้าต่างใหม่)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (เปิดหน้าต่างใหม่)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Source‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

Indexed‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (เปิดหน้าต่างใหม่)

Viscoelastic Tests to Identify Surgical or Coagulopathic Bleeding